Advanced age and the clinical outcomes of transcatheter aortic valve implantation
- PMID: 25009568
- PMCID: PMC4076458
- DOI: 10.3969/j.issn.1671-5411.2014.02.004
Advanced age and the clinical outcomes of transcatheter aortic valve implantation
Abstract
Aortic valve stenosis (AS) is common in the elderly. Although surgical replacement of the valve has been the gold standard of management, many patients have been excluded from surgery because they were very old, frail, or had co-morbidities that increased operative risks. In the last decade, transcatheter aortic valve implantation (TAVI) has emerged as a new treatment option suitable for these patients. This article reviews the available literature on the role of TAVI in elderly patients with severe aortic stenosis. Published studies showed that elderly individuals who underwent TAVI experienced better in-hospital recovery, and similar short and mid-term mortality compared to those underwent surgical treatment of AS. However, long-term outcomes of TAVI in elderly patients are still unknown. The available data in the literature on the effect of advanced age on clinical outcomes of TAVI are limited, but the data that are available suggest that TAVI is a beneficial and tolerable procedure in very old patients. Some of the expected complications after TAVI are reported more in the oldest patients such as vascular injures. Other complications were comparable in TAVI patients regardless of their age group. However, very old patients may need closer monitoring to avoid further morbidities and mortality.
Keywords: Aortic stenosis; Geriatric; Surgical aortic valve replacement; Transcatheter aortic valve implantation.
Figures

Similar articles
-
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.J Cardiovasc Med (Hagerstown). 2018 May;19(5):197-210. doi: 10.2459/JCM.0000000000000636. J Cardiovasc Med (Hagerstown). 2018. PMID: 29578921 Review.
-
[Multidimensional geriatric assessment before transcatheter aortic valve implantation in frail elderly patients with one-year follow-up. Cardio-geriatrician collaboration benefits?].Ann Cardiol Angeiol (Paris). 2016 Sep;65(4):250-4. doi: 10.1016/j.ancard.2016.05.001. Epub 2016 Jul 15. Ann Cardiol Angeiol (Paris). 2016. PMID: 27427467 French.
-
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients over 85 years old.Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):526-532. doi: 10.1093/icvts/ivx180. Interact Cardiovasc Thorac Surg. 2017. PMID: 28962494
-
[Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].Dtsch Med Wochenschr. 2010 Aug;135(33):1589-95. doi: 10.1055/s-0030-1262450. Epub 2010 Aug 17. Dtsch Med Wochenschr. 2010. PMID: 20717862 German.
-
Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Low Surgical Risk.Am J Cardiol. 2020 Feb 1;125(3):459-468. doi: 10.1016/j.amjcard.2019.10.036. Epub 2019 Nov 8. Am J Cardiol. 2020. PMID: 31784051 Review.
Cited by
-
Change in quality of life after transcatheter aortic valve implantation and aortic valve replacement surgery in Australian patients aged ≥ 75 years: the effects of EuroSCORE and patient operability.J Geriatr Cardiol. 2015 Jan;12(1):30-6. doi: 10.11909/j.issn.1671-5411.2015.01.004. J Geriatr Cardiol. 2015. PMID: 25678902 Free PMC article.
-
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.PLoS One. 2016 May 12;11(5):e0155398. doi: 10.1371/journal.pone.0155398. eCollection 2016. PLoS One. 2016. PMID: 27171441 Free PMC article.
-
Never Too Late: A Case Report on Transcatheter Aortic Valve Implantation in a 97-Year-Old Patient.Geriatrics (Basel). 2017 Jul 17;2(3):25. doi: 10.3390/geriatrics2030025. Geriatrics (Basel). 2017. PMID: 31011035 Free PMC article.
-
Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3.Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2202577119. doi: 10.1073/pnas.2202577119. Epub 2022 Aug 29. Proc Natl Acad Sci U S A. 2022. PMID: 36037361 Free PMC article.
-
Development of a Novel Human Cell-Derived Tissue-Engineered Heart Valve for Transcatheter Aortic Valve Replacement: an In Vitro and In Vivo Feasibility Study.J Cardiovasc Transl Res. 2018 Dec;11(6):470-482. doi: 10.1007/s12265-018-9821-1. Epub 2018 Aug 13. J Cardiovasc Transl Res. 2018. PMID: 30105605
References
-
- Varadarajan P, Kapoor N, Bansal RC, et al. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg. 2006;30:722–727. - PubMed
-
- Huber CH, Goeber V, Berdat P, et al. Benefits of cardiac surgery in octogenarians—a postoperative quality of life assessment. Eur J Cardiothorac Surg. 2007;31:1099–1105. - PubMed
-
- Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–2720. - PubMed
-
- Sawaya F, Stewart J, Babaliaros V. Aortic stenosis: who should undergo surgery, transcatheter valve replacement? Cleve Clin J Med. 2012;79:487–497. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials